ZESTORETIC - 0310-0145-11 - (Lisinopril and Hydrochlorothiazide)

Alphabetical Index


Drug Information of ZESTORETIC

Product NDC: 0310-0145
Proprietary Name: ZESTORETIC
Non Proprietary Name: Lisinopril and Hydrochlorothiazide
Active Ingredient(s): 25; 20    mg/1; mg/1 & nbsp;   Lisinopril and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of ZESTORETIC

Product NDC: 0310-0145
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019888
Marketing Category: NDA
Start Marketing Date: 20100727

Package Information of ZESTORETIC

Package NDC: 0310-0145-11
Package Description: 100 TABLET in 1 BOTTLE (0310-0145-11)

NDC Information of ZESTORETIC

NDC Code 0310-0145-11
Proprietary Name ZESTORETIC
Package Description 100 TABLET in 1 BOTTLE (0310-0145-11)
Product NDC 0310-0145
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lisinopril and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20100727
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
Strength Number 25; 20
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of ZESTORETIC


General Information